1. Home
  2. BWAY

as of 02-17-2026 3:39pm EST

$25.14
+$2.15
+9.35%
Stocks Health Care Medical/Dental Instruments Nasdaq

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Founded: 2003 Country:
N/A
Employees: N/A City: N/A
Market Cap: 450.8M IPO Year: N/A
Target Price: $26.50 AVG Volume (30 days): 99.1K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $7.84 - $25.65 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 314.08% Revenue Growth (next year): 23.37%
P/E Ratio: 75.68 Index: N/A
Free Cash Flow: N/A FCF Growth: +207.48%

AI-Powered BWAY Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 73.86%
73.86%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest BrainsWay Ltd. News

BWAY Breaking Stock News: Dive into BWAY Ticker-Specific Updates for Smart Investing

All BWAY News

Share on Social Networks: